Live Ventures Incorporated (LIVE)
Price:
12.00 USD
( + 0.25 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Leslie's, Inc.
VALUE SCORE:
5
2nd position
Tile Shop Holdings, Inc.
VALUE SCORE:
5
The best
Pinnacle Food Group Limited Class A Common Shares
VALUE SCORE:
7
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
DESCRIPTION
Live Ventures Incorporated, together with its subsidiaries, engages in the flooring and steel manufacturing, and retail businesses in the United States. The company's Flooring Manufacturing segment manufactures and sells carpets and rugs, and yarn products focusing on the residential, niche commercial, and hospitality end-markets; and resells hard surface flooring products. This segment serves flooring dealers, home centers, and other flooring manufacturers, as well as directly to end users. Its Steel Manufacturing segment manufactures and sells pre-finished de-carb free tool and die steel products, such as deluxe alloy plates, deluxe tool steel plates, precision ground flat stock products, and drill rods. This segment serves steel distributors and steel service centers. The company's Retail segment operates 63 specialty entertainment retail storefronts that offer entertainment products, including new and pre-owned movies, video games, and music products, as well as ancillary products, such as books, comics, toys, and collectibles. It buys, sells, and trades in new and pre-owned movies, music, video games, electronics, and collectibles through 35 Vintage Stock, 3 V-Stock, 13 Movie Trading company, and 12 EntertainMart retail locations in Arkansas, Colorado, Idaho, Illinois, Kansas, Missouri, Nebraska, New Mexico, Oklahoma, Texas, and Utah, as well as sells new and used movies, video games, music, and toys through Website, vintagestock.com. This segment also offers services to customers, such as rentals, special orders, disc and video game hardware repair services, and other services. Its Corporate and Other segment provides product and service for new customers. Live Ventures Incorporated was incorporated in 1968 and is based in Las Vegas, Nevada.
NEWS
Senti Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
globenewswire.com
2025-05-22 16:05:00SOUTH SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that Timothy Lu, M.D.
Akari Therapeutics to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
globenewswire.com
2025-05-22 09:00:00BOSTON and LONDON, May 22, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced that Abizer Gaslightwala, President and CEO of Akari, will present and discuss recent corporate events at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar on Thursday, May 29, 2025 at 2:00 PM ET.
Live Ventures Incorporated (LIVE) Q2 2025 Earnings Call Transcript
seekingalpha.com
2025-05-09 05:14:50Live Ventures Incorporated (NASDAQ:LIVE ) Q2 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Jon Isaac - President, Chief Executive Officer, Director David Verret - Chief Financial Officer Greg Powell - Director of Investor Relations Conference Call Participants Joseph Kowalsky - JD Investments Operator Good day, everyone. And welcome to the Live Ventures Fiscal YearSecond Quarter 2025 Conference Call.
Live Ventures Reports Fiscal Second Quarter 2025 Financial Results
globenewswire.com
2025-05-08 08:30:00LAS VEGAS, May 08, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, today announced financial results for its fiscal second quarter 2025 ended March 31, 2025. Fiscal Second Quarter 2025 Key Highlights: Revenue was $107.0 million, compared to $118.6 million in the prior year period Operating income increased $2.9 million to $2.1 million, compared to an operating loss of $0.8 million in the prior year period Successfully negotiated a $19 million reduction on the balance owed under the Flooring Liquidators, Inc. (“Flooring Liquidators”) seller note, which, when including the cancellation of accrued interest and other items, resulted in a $22.8 million net gain for Live Ventures Income before provision for income taxes was $21.1 million, compared to the prior year period loss before benefit from income taxes of $4.5 million.
Live Ventures to Issue Fiscal Second Quarter 2025 Financial Results and Hold Earnings Conference Call on May 8, 2025
globenewswire.com
2025-05-01 08:30:00LAS VEGAS, May 01, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (NASDAQ: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, will issue its financial results for its fiscal second quarter ended March 31, 2025, before the market opens on Thursday, May 8, 2025. The Company will hold a conference call to discuss the results on Thursday, May 8, 2025, at 2:00 p.m. Pacific Standard Time (5:00 p.m. Eastern Standard Time).
Live Energy Grants Option for 100% Interest in Saskatchewan Claims
newsfilecorp.com
2025-04-10 17:05:00Vancouver, British Columbia--(Newsfile Corp. - April 10, 2025) - Live Energy Minerals Corp. (CSE: LIVE) (OTC Pink: GTREF) ("LIVE" or the "Company") is pleased to announce that it has entered into an option agreement dated April 9, 2025 (the "Option Agreement") with an arm's length purchaser (the "Purchaser"), pursuant to which the Company has granted the Purchaser the exclusive option to acquire a 100% undivided interest in two mineral claims totaling approximately 5,355 hectares located in the Province of Saskatchewan (the "Property"). Pursuant to the Option Agreement, the Company has granted the Purchaser the exclusive right to acquire a 100% interest in the Property (the "Option").
Live Ventures CEO Announces Purchase of 55,796 Shares of the Company's Common Stock in the Open Market
globenewswire.com
2025-03-28 08:30:00LAS VEGAS, March 28, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, today announced that Jon Isaac, its President and Chief Executive Officer, acquired 55,796 shares of the Company's common stock in open market transactions valued at approximately $385,000.
Live Ventures Incorporated (LIVE) Q1 2025 Earnings Call Transcript
seekingalpha.com
2025-02-06 21:24:26Live Ventures Incorporated (NASDAQ:LIVE ) Q1 2025 Earnings Conference Call February 5, 2025 5:00 PM ET Company Participants Greg Powell - Director, IR David Verret - CFO Conference Call Participants Joseph Kowalsky - JD Investments Operator Welcome to the Live Ventures FY 2025 First Quarter Earnings Conference Call. [Operator Instructions] I would now like to turn the call over to Greg Powell, Director of Investor Relations.
Live Ventures Reports Fiscal First Quarter 2025 Financial Results
globenewswire.com
2025-02-06 08:30:00LAS VEGAS, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, today announced financial results for its fiscal first quarter 2025 ended December 31, 2024.
Live Ventures to Issue Fiscal First Quarter 2025 Financial Results and Hold Earnings Conference Call on February 6, 2025
globenewswire.com
2025-01-30 08:30:00LAS VEGAS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (NASDAQ: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, will issue its financial results for its fiscal first quarter ended December 31, 2024, before the market opens on Thursday, February 6, 2025. The Company will hold a conference call to discuss the results on Thursday, February 6, 2025, at 2:00 p.m. Pacific Standard Time (5:00 p.m. Eastern Standard Time).
Outlook Therapeutics® to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
globenewswire.com
2025-01-22 09:05:00ISELIN, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) earlier this year for the first authorized use of an ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration (wet AMD), today announced that Lawrence A.
Sonnet BioTherapeutics to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
globenewswire.com
2025-01-22 08:35:00Live webcast on Wednesday, January 29 th at 2:40 PM ET PRINCETON, NJ, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced that Pankaj Mohan, Ph.D., Chief Executive Officer of Sonnet will present at LIVE!
Live Ventures Incorporated (LIVE) Q4 2024 Earnings Call Transcript
seekingalpha.com
2024-12-12 19:07:52Live Ventures Incorporated (NASDAQ:LIVE ) Q4 2024 Earnings Conference Call December 12, 2024 5:00 PM ET Company Participants Greg Powell - Director of Investor Relations David Verret - Chief Financial Officer Jon Isaac - President and Chief Executive Officer Conference Call Participants Joseph Kowalsky - JD Investments Operator Welcome to the Live Ventures Fiscal Year 2024 Year-End Earnings Conference Call. At this time, all participants are in a listen-only mode.
Live Ventures Reports Fiscal Year 2024 Financial Results
globenewswire.com
2024-12-12 08:30:00LAS VEGAS, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, today announced financial results for its fiscal year ended September 30, 2024.
Live Ventures to Issue Fiscal Year End 2024 Financial Results and Hold Earnings Conference Call on December 12, 2024
globenewswire.com
2024-12-05 08:30:00LAS VEGAS, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (NASDAQ: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, will issue its financial results for its fiscal year ended September 30, 2024, before the market opens on Thursday, December 12, 2024. The Company will hold a conference call to discuss the results on Thursday, December 12, 2024, at 2:00 p.m. Pacific Standard Time (5:00 p.m. Eastern Standard Time).
Moleculin to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
prnewswire.com
2024-08-26 08:30:00Live webcast on Wednesday, August 28 th at 3:40 PM ET HOUSTON , Aug. 26, 2024 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a Phase 3 clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced that Walter Klemp, Chairman and Chief Executive Officer of Moleculin will present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar on Wednesday, August 28, 2024 at 3:40 PM ET.
Senti Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
globenewswire.com
2025-05-22 16:05:00SOUTH SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that Timothy Lu, M.D.
Akari Therapeutics to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
globenewswire.com
2025-05-22 09:00:00BOSTON and LONDON, May 22, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced that Abizer Gaslightwala, President and CEO of Akari, will present and discuss recent corporate events at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar on Thursday, May 29, 2025 at 2:00 PM ET.
Live Ventures Incorporated (LIVE) Q2 2025 Earnings Call Transcript
seekingalpha.com
2025-05-09 05:14:50Live Ventures Incorporated (NASDAQ:LIVE ) Q2 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Jon Isaac - President, Chief Executive Officer, Director David Verret - Chief Financial Officer Greg Powell - Director of Investor Relations Conference Call Participants Joseph Kowalsky - JD Investments Operator Good day, everyone. And welcome to the Live Ventures Fiscal YearSecond Quarter 2025 Conference Call.
Live Ventures Reports Fiscal Second Quarter 2025 Financial Results
globenewswire.com
2025-05-08 08:30:00LAS VEGAS, May 08, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, today announced financial results for its fiscal second quarter 2025 ended March 31, 2025. Fiscal Second Quarter 2025 Key Highlights: Revenue was $107.0 million, compared to $118.6 million in the prior year period Operating income increased $2.9 million to $2.1 million, compared to an operating loss of $0.8 million in the prior year period Successfully negotiated a $19 million reduction on the balance owed under the Flooring Liquidators, Inc. (“Flooring Liquidators”) seller note, which, when including the cancellation of accrued interest and other items, resulted in a $22.8 million net gain for Live Ventures Income before provision for income taxes was $21.1 million, compared to the prior year period loss before benefit from income taxes of $4.5 million.
Live Ventures to Issue Fiscal Second Quarter 2025 Financial Results and Hold Earnings Conference Call on May 8, 2025
globenewswire.com
2025-05-01 08:30:00LAS VEGAS, May 01, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (NASDAQ: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, will issue its financial results for its fiscal second quarter ended March 31, 2025, before the market opens on Thursday, May 8, 2025. The Company will hold a conference call to discuss the results on Thursday, May 8, 2025, at 2:00 p.m. Pacific Standard Time (5:00 p.m. Eastern Standard Time).
Live Energy Grants Option for 100% Interest in Saskatchewan Claims
newsfilecorp.com
2025-04-10 17:05:00Vancouver, British Columbia--(Newsfile Corp. - April 10, 2025) - Live Energy Minerals Corp. (CSE: LIVE) (OTC Pink: GTREF) ("LIVE" or the "Company") is pleased to announce that it has entered into an option agreement dated April 9, 2025 (the "Option Agreement") with an arm's length purchaser (the "Purchaser"), pursuant to which the Company has granted the Purchaser the exclusive option to acquire a 100% undivided interest in two mineral claims totaling approximately 5,355 hectares located in the Province of Saskatchewan (the "Property"). Pursuant to the Option Agreement, the Company has granted the Purchaser the exclusive right to acquire a 100% interest in the Property (the "Option").
Live Ventures CEO Announces Purchase of 55,796 Shares of the Company's Common Stock in the Open Market
globenewswire.com
2025-03-28 08:30:00LAS VEGAS, March 28, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, today announced that Jon Isaac, its President and Chief Executive Officer, acquired 55,796 shares of the Company's common stock in open market transactions valued at approximately $385,000.
Live Ventures Incorporated (LIVE) Q1 2025 Earnings Call Transcript
seekingalpha.com
2025-02-06 21:24:26Live Ventures Incorporated (NASDAQ:LIVE ) Q1 2025 Earnings Conference Call February 5, 2025 5:00 PM ET Company Participants Greg Powell - Director, IR David Verret - CFO Conference Call Participants Joseph Kowalsky - JD Investments Operator Welcome to the Live Ventures FY 2025 First Quarter Earnings Conference Call. [Operator Instructions] I would now like to turn the call over to Greg Powell, Director of Investor Relations.
Live Ventures Reports Fiscal First Quarter 2025 Financial Results
globenewswire.com
2025-02-06 08:30:00LAS VEGAS, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, today announced financial results for its fiscal first quarter 2025 ended December 31, 2024.
Live Ventures to Issue Fiscal First Quarter 2025 Financial Results and Hold Earnings Conference Call on February 6, 2025
globenewswire.com
2025-01-30 08:30:00LAS VEGAS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (NASDAQ: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, will issue its financial results for its fiscal first quarter ended December 31, 2024, before the market opens on Thursday, February 6, 2025. The Company will hold a conference call to discuss the results on Thursday, February 6, 2025, at 2:00 p.m. Pacific Standard Time (5:00 p.m. Eastern Standard Time).
Outlook Therapeutics® to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
globenewswire.com
2025-01-22 09:05:00ISELIN, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) earlier this year for the first authorized use of an ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration (wet AMD), today announced that Lawrence A.
Sonnet BioTherapeutics to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
globenewswire.com
2025-01-22 08:35:00Live webcast on Wednesday, January 29 th at 2:40 PM ET PRINCETON, NJ, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced that Pankaj Mohan, Ph.D., Chief Executive Officer of Sonnet will present at LIVE!
Live Ventures Incorporated (LIVE) Q4 2024 Earnings Call Transcript
seekingalpha.com
2024-12-12 19:07:52Live Ventures Incorporated (NASDAQ:LIVE ) Q4 2024 Earnings Conference Call December 12, 2024 5:00 PM ET Company Participants Greg Powell - Director of Investor Relations David Verret - Chief Financial Officer Jon Isaac - President and Chief Executive Officer Conference Call Participants Joseph Kowalsky - JD Investments Operator Welcome to the Live Ventures Fiscal Year 2024 Year-End Earnings Conference Call. At this time, all participants are in a listen-only mode.
Live Ventures Reports Fiscal Year 2024 Financial Results
globenewswire.com
2024-12-12 08:30:00LAS VEGAS, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, today announced financial results for its fiscal year ended September 30, 2024.
Live Ventures to Issue Fiscal Year End 2024 Financial Results and Hold Earnings Conference Call on December 12, 2024
globenewswire.com
2024-12-05 08:30:00LAS VEGAS, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (NASDAQ: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, will issue its financial results for its fiscal year ended September 30, 2024, before the market opens on Thursday, December 12, 2024. The Company will hold a conference call to discuss the results on Thursday, December 12, 2024, at 2:00 p.m. Pacific Standard Time (5:00 p.m. Eastern Standard Time).
Moleculin to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
prnewswire.com
2024-08-26 08:30:00Live webcast on Wednesday, August 28 th at 3:40 PM ET HOUSTON , Aug. 26, 2024 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a Phase 3 clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced that Walter Klemp, Chairman and Chief Executive Officer of Moleculin will present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar on Wednesday, August 28, 2024 at 3:40 PM ET.